Summary

Efalizumab is a humanized monoclonal antibody binding to lymphocyte function-associated antigen (LFA-1). LFA-1 belongs to the family of the |32 integrins and is expressed on the surface of T cells (CD4+ cells, T-help-er cells). It is involved in several T-cell activities, such as T-cell activation and migration, as well as T-cell adhe sion during cellular interactions that are important for induction and maintenance of immune-mediated inflammatory processes. Efalizumab (Raptiva) is indicated for treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or are intolerant to, other systemic therapies including cyclo-sporine, methotrexate and PUVA.

Was this article helpful?

0 0
Natural Treatments For Psoriasis

Natural Treatments For Psoriasis

Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.

Get My Free Ebook


Post a comment